LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
European Medicines Agency (Ema)
Headquarters:
Amsterdam, Netherlands
Website:
http://www.ema.europa.eu
Year Founded:
1995
Status:
Non-biopharma
Biopharma related deals can be found by searching the organization's name in the
Deals
Module.
BioCentury
|
Feb 3, 2025
Guest Commentary
Rebuilding trust in FDA through labeling clarity and transparency
Regulatory agency must be proactive in fighting the surge in skepticism about the drugs and vaccines it regulates
Read More
BioCentury
|
Oct 18, 2024
Management Tracks
Hoess succeeds Crawford at ViaNautis
Plus: Korenberg now CFO of Palvella and updates from Moffitt and CHMP
Read More
BioCentury
|
Sep 19, 2024
Management Tracks
EMA names Sepodes CHMP chair, Bell leaving Valo as CEO, and more
Plus: Autolus hires Matthias Will as CDO, and updates from HotSpot, Prilenia, Frazier, BIA and BioCentriq
Read More
BioCentury
|
Jan 25, 2024
Data Byte
EMA’s CHMP recommended fewer expedited approvals in 2023
The year also hit a new record for applications withdrawn during review
Read More
BioCentury
|
Nov 1, 2023
Regulation
FDA illuminates the single trial path
How one trial plus confirmatory evidence can add up to approval
Read More
BioCentury
|
Jun 19, 2023
Regulation
EMA’s Cooke, what’s next for IPSCs, and Leerink is back
Plus: a conversation with Forbion, and why Senate Democrats are holding up confirmation of a new NIH director
Read More
BioCentury
|
Jun 15, 2023
Politics, Policy & Law
Next up for EMA head Emer Cooke: pharma legislation
Having steered Europe’s regulatory agency through the pandemic, her next mark will be how she tackles the upcoming pharma legislation
Read More
BioCentury
|
Mar 2, 2023
Politics, Policy & Law
Europe’s shrinking regulatory protections
Leaked EU pharma legislation proposes to reduce regulatory protections for NMEs, orphan drugs
Read More
BioCentury
|
Mar 2, 2023
Politics, Policy & Law
EC to propose AMR vouchers, cutting red tape
Leaked draft pharma legislation seeks to streamline European drug oversight, incentivize antimicrobials
Read More
BioCentury
|
Dec 9, 2022
Finance
Dec. 8 Quick Takes: ADC play Dantari debuts with $47M led by Westlake
Plus: Sanofi ends SHP2 deal with Revolution and updates from Novartis, Daiichi, Takeda, Autolus, C-PATH and more
Read More
Items per page:
10
1 - 10 of 671